Format

Send to

Choose Destination
See comment in PubMed Commons below
Proteomics Clin Appl. 2012 Jan;6(1-2):42-59. doi: 10.1002/prca.201100062. Epub 2011 Dec 27.

Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies.

Author information

1
Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, Australia.

Abstract

The widespread clinical adoption of protein biomarkers with diagnostic, prognostic and/or predictive value remains a formidable challenge for the biomedical community. From discovery to validation, the path to biomarkers of clinical relevance abounds with many protein candidates, yet so few concrete examples have been substantiated. In this review, we focus on the recent adoption of selected reaction monitoring (SRM) of plasma proteins in the path to clinical use for a broad range of diseases including cancer, cardiovascular disease, genetic disorders and various metabolic disorders. Recent progress reveals a promising outlook for clinical applications using SRM, which now provides the routine analysis of clinically relevant protein markers at low nanogram per millilitre in plasma.

PMID:
22213646
DOI:
10.1002/prca.201100062
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center